Growth Metrics

Opus Genetics (IRD) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Opus Genetics 357.99 Mn 298.03 Mn - -22.18%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -22.18%
Dec 31, 2025 -21.03%
Sep 30, 2023 -57.14%
Jun 30, 2023 -50.00%
Mar 31, 2023 -44.44%
Dec 31, 2022 -40.00%
Sep 30, 2022 -36.36%
Jun 30, 2022 -33.33%
Mar 31, 2022 -30.77%
Dec 31, 2021 -28.57%
Sep 30, 2021 -77.44%
Jun 30, 2021 -79.06%
Mar 31, 2021 -80.46%
Dec 31, 2020 -36.36%
Sep 30, 2020 -42.84%
Jun 30, 2020 -39.47%
Mar 31, 2020 -32.83%
Dec 31, 2019 -80.44%
Sep 30, 2019 -30.92%
Jun 30, 2019 -3.15%
Mar 31, 2019 -9.47%
Dec 31, 2018 -7.40%
Sep 30, 2018 56.19%
Jun 30, 2018 12.88%
Mar 31, 2018 30.70%
Dec 31, 2017 37.01%
Sep 30, 2017 -18.53%
Jun 30, 2017 -17.79%
Mar 31, 2017 -24.83%
Dec 31, 2016 -21.48%
Sep 30, 2016 -12.30%
Jun 30, 2016 35.35%
Mar 31, 2016 39.40%
Dec 31, 2015 44.57%
Sep 30, 2015 51.77%
Jun 30, 2015 28.21%
Mar 31, 2015 33.33%
Dec 31, 2014 19.83%
Sep 30, 2014 3.53%
Jun 30, 2014 72.41%
Mar 31, 2014 37.86%
Dec 31, 2013 24.96%
Sep 30, 2013 12.89%
Jun 30, 2013 -51.83%
Mar 31, 2013 -48.16%
Dec 31, 2012 -44.83%
Sep 30, 2012 -32.98%
Jun 30, 2012 -27.58%
Dec 31, 2011 -23.49%